Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Cemex SAB de CV has a consensus price target of $7.14 based on the ratings of 9 analysts. The high is $9 issued by Goldman Sachs on February 27, 2025. The low is $4.9 issued by Redburn Partners on December 8, 2022. The 3 most-recent analyst ratings were released by Goldman Sachs, RBC Capital, and RBC Capital on February 27, 2025, February 10, 2025, and December 11, 2024, respectively. With an average price target of $6.67 between Goldman Sachs, RBC Capital, and RBC Capital, there's an implied 17.06% upside for Cemex SAB de CV from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
02/27/2025 | Buy Now | 58.03% | Goldman Sachs | Bruno Amorim56% | $8 → $9 | Maintains | Buy | Get Alert |
02/10/2025 | Buy Now | 5.36% | RBC Capital | Anthony Codling57% | $5 → $6 | Maintains | Underperform | Get Alert |
12/11/2024 | Buy Now | -12.2% | RBC Capital | Anthony Codling57% | $6 → $5 | Downgrade | Sector Perform → Underperform | Get Alert |
11/01/2024 | Buy Now | 43.99% | Scotiabank | Francisco Suarez67% | $8.9 → $8.2 | Maintains | Sector Outperform | Get Alert |
10/29/2024 | Buy Now | 56.28% | Scotiabank | Francisco Suarez67% | $10 → $8.9 | Maintains | Sector Outperform | Get Alert |
10/29/2024 | Buy Now | 5.36% | RBC Capital | Anthony Codling57% | $6.5 → $6 | Maintains | Sector Perform | Get Alert |
10/29/2024 | Buy Now | 40.47% | Barclays | Benjamin Theurer59% | $9 → $8 | Maintains | Overweight | Get Alert |
10/29/2024 | Buy Now | 5.36% | JP Morgan | Adrian Huerta65% | $7 → $6 | Downgrade | Overweight → Neutral | Get Alert |
10/09/2024 | Buy Now | 22.91% | JP Morgan | Adrian Huerta65% | $8 → $7 | Maintains | Overweight | Get Alert |
10/08/2024 | Buy Now | 14.14% | RBC Capital | Anthony Codling57% | $9 → $6.5 | Upgrade | Underperform → Sector Perform | Get Alert |
08/21/2024 | Buy Now | 40.47% | JP Morgan | Adrian Huerta65% | → $8 | Reinstates | Overweight → Overweight | Get Alert |
07/31/2024 | Buy Now | 58.03% | Barclays | Benjamin Theurer59% | $9 → $9 | Upgrade | Equal-Weight → Overweight | Get Alert |
07/08/2024 | Buy Now | 49.25% | JP Morgan | Adrian Huerta65% | $9.5 → $8.5 | Maintains | Overweight | Get Alert |
05/14/2024 | Buy Now | 58.03% | RBC Capital | Anthony Codling57% | → $9 | Initiates | → Underperform | Get Alert |
04/26/2024 | Buy Now | 75.59% | Goldman Sachs | Bruno Amorim56% | $9 → $10 | Maintains | Buy | Get Alert |
04/24/2024 | Buy Now | 58.03% | B of A Securities | Carlos Peyrelongue58% | $9 → $9 | Downgrade | Buy → Neutral | Get Alert |
02/09/2024 | Buy Now | 58.03% | Barclays | Benjamin Theurer59% | → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/09/2024 | Buy Now | 58.03% | B of A Securities | Carlos Peyrelongue58% | $8.2 → $9 | Upgrade | Neutral → Buy | Get Alert |
11/02/2023 | Buy Now | 43.99% | Citigroup | Andres Cardona59% | → $8.2 | Reinstates | → Buy | Get Alert |
07/28/2023 | Buy Now | 58.03% | JP Morgan | Adrian Huerta65% | $8 → $9 | Maintains | Overweight | Get Alert |
05/15/2023 | Buy Now | 26.43% | B of A Securities | Carlos Peyrelongue58% | → $7.2 | Downgrade | Buy → Neutral | Get Alert |
05/05/2023 | Buy Now | 22.91% | Citigroup | Andres Cardona59% | → $7 | Downgrade | Buy → Neutral | Get Alert |
05/04/2023 | Buy Now | 58.03% | Goldman Sachs | Bruno Amorim56% | $5.9 → $9 | Upgrade | Neutral → Buy | Get Alert |
02/16/2023 | Buy Now | 3.6% | Goldman Sachs | Bruno Amorim56% | $5.2 → $5.9 | Maintains | Neutral | Get Alert |
12/08/2022 | Buy Now | -13.96% | Redburn Partners | Yuri Serov1% | → $4.9 | Initiates | → Neutral | Get Alert |
06/10/2022 | Buy Now | -12.2% | Berenberg | Harry Goad10% | $7.2 → $5 | Downgrade | Buy → Hold | Get Alert |
04/05/2022 | Buy Now | 5.36% | Goldman Sachs | Bruno Amorim56% | $9.2 → $6 | Downgrade | Buy → Neutral | Get Alert |
The latest price target for Cemex (NYSE:CX) was reported by Goldman Sachs on February 27, 2025. The analyst firm set a price target for $9.00 expecting CX to rise to within 12 months (a possible 58.03% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Cemex (NYSE:CX) was provided by Goldman Sachs, and Cemex maintained their buy rating.
The last upgrade for Cemex SAB de CV happened on October 8, 2024 when RBC Capital raised their price target to $6.5. RBC Capital previously had an underperform for Cemex SAB de CV.
The last downgrade for Cemex SAB de CV happened on December 11, 2024 when RBC Capital changed their price target from $6 to $5 for Cemex SAB de CV.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cemex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cemex was filed on February 27, 2025 so you should expect the next rating to be made available sometime around February 27, 2026.
While ratings are subjective and will change, the latest Cemex (CX) rating was a maintained with a price target of $8.00 to $9.00. The current price Cemex (CX) is trading at is $5.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.